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Abstract Worldwide, the incidence of obesity has in-
creased dramatically over the past decades. More knowl-
edge about the complex etiology of obesity is needed in
order to find additional approaches for treatment and pre-
vention. Investigating the exome sequencing data of 30
extremely obese subjects (BMI 45–65 kg/m2) shows that
predicted damaging missense variants in olfactory receptor
genes on chromosome 1q and rare predicted damaging
variants in the protocadherin (PCDH) beta-cluster genes
on chromosome 5q31, reported in our previous work, co-
localize in subjects with extreme obesity. This implies a
synergistic effect between genetic variation in these gene
clusters in the predisposition to extreme obesity. Evidence
for a general involvement of the olfactory transduction
pathway on itself could not be found. Bioinformatic ana-
lysis indicates a specific involvement of the PCDH beta-
cluster genes in controlling tissue development. Further
mechanistic insight needs to await the identification of the
ligands of the 1q olfactory receptors. Eventually, this may
provide the possibility to manipulate food flavor in a way
to reduce the risk of overeating and of extreme obesity in
genetically predisposed subjects.
Keywords Extreme obesity  Genetic predisposition 
Olfactory system  Protocadherins
Introduction
Worldwide, the incidence of obesity has increased dra-
matically over the past decades and all kinds of measures
ranging from dietary and lifestyle interventions to bariatric
surgery are being taken to revert this situation, albeit with
limited success. Apparently, more knowledge about the
complex etiology of obesity is needed in order to find ad-
ditional approaches for treatment and prevention. Obesity
and parameters of adiposity are to a considerable extent
determined by genetic factors. Heritability estimates for
obesity in different studies amount to at least 0.4 (Walley
et al. 2006; Farooqi and O’Rahilly 2007; Berndt et al.
2013). Knowledge of those factors and the processes that
they influence provides possibilities for diagnostic testing
and counseling in addition to development of novel inter-
vention methods. Unfortunately, more than 90 % of the
genetic background is still unexplained (Speliotes et al.
2010; Loos 2012; Wheeler et al. 2013); thus, a further
search for obesity-related genes is warranted. Recently,
using functional clustering analysis of genes with rare
variants, we have shown that in people with extreme
obesity (BMI 45–65 kg/m2), the protocadherin (PCDH)
genes on chromosome 5q31 harbor a surplus of rare var-
iation with a moderate-to-high predicted biological effect
(Mariman et al. 2014).
Studies in the mouse have provided evidence for a
prominent role of the PCDH gene cluster in the
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development of the olfactory system (Hasegawa et al.
2012; Ledderose et al. 2013; Hirano et al. 2012). We
therefore wondered whether the previously identified rare
PCDH gene variation (Mariman et al. 2014) and damaging
variation in the genes of the olfactory transduction pathway
might work synergistically in the predisposition to extreme
obesity. In that case, damaging missense variants in the
genes of the olfactory transduction pathway might occur
more often in the extreme obese subjects carrying the rare
potentially damaging variation in the PCDH genes than in
the non-carrier subjects. In the present study, we analyzed
genetic variants of the olfactory system in relation to the
earlier reported variants in the PCDH genes in 30 extreme
obese subjects.
Materials and methods
Subjects
The selection of the subjects has been described before
(Mariman et al. 2014). In short, from 561 obese individuals
who attended the private obesity clinic CO-EUR (http://
www.co-eur.eu/), 30 (19 females, 11 males) relatively
young (average age 29.7 years, range 19–40.4 years) ex-
tremely obese (average BMI 51.1 kg/m2, range
45.3–65.1 kg/m2) Caucasian subjects were selected. Writ-
ten informed consent for genetic studies was obtained from
all participants, and permission was granted by the Medical
Research Ethics Committee of the Maastricht University
Medical Center. For these subjects, only weight, length,
age and sex were registered, and no clinical biochemical
data were available.
DNA isolation and sequencing
From peripheral blood leukocytes, genomic DNA was
isolated using the QIAamp DNA blood kit (Qiagen,
Amsterdam, The Netherlands) and was then outsourced for
whole exome sequencing in a CLIA-certified laboratory
(EdgeBio, http://www.edgebio.com/). The Nimblegen cap-
ture kit was used for the selection of genomic coding re-
gions, followed by sequencing on the Illumina HiSeq 2000.
For our exome sequencing, the target 64 Mb consisted
of 34-Mb exons. The average median whole targeted se-
quencing read depth was 50. For all samples, 94.6 % of
bases had a read depth[10, and 87.2 % of bases had a read
depth [20. 84–86 % of the reads mapped to the target
regions, and 14–16 % was off target.
Sequence results were compared with GRCh37 (b37) as
the reference genome (http://www.ncbi.nlm.nih.gov/pro
jects/genome/assembly/grc/human/). For every subject,
data were returned in excel-readable format as a SNP file
and an indel file (insertion/deletion). Only the SNP files
were used for the present study. Information was provided
concerning genetic data (chromosome, cytoband, reference
position, gene, zygosity, rs number, alleles, etc.), quality of
the sequencing (Phred quality score, depth) and predicted
biological effect by various methods (SNPeffect (Reumers
et al. 2005), SIFT score (http://sift.jcvi.org/), PolyPhen2
class and score (http://genetics.bwh.harvard.edu/pph2/),
etc.). In addition, the corresponding KEGG pathway
identifier(s) (http://www.genome.jp/kegg/) were given for
the genes.
Identification of PCDH-variant carriers
Previously, we analyzed the sequencing data for the pres-
ence of rare variants with a moderate-to-high predicted
biological damaging effect in functional gene clusters
(Mariman et al. 2014). PCDH gene clusters on chromo-
some 5q31 displayed a high frequency of such variants in
the extreme obese cohort. In the present study, we com-
pared genetic data between carriers of these PCDH variants
and the individuals not carrying such variants in our cohort
(non-carriers). In Table 1, PCDH-variant carriers are listed
with information of the PCDH genes in which their rare
variants occurred.
Selection of variants
For the present study, we focused on missense variants
with a predicted damaging impact on protein function
present in genes that had already been functionally anno-
tated in KEGG pathways. The selection route for these
variants is depicted in Fig. 1. In short, all missense variants
detected in the 30 extremely obese subjects with a Phred
quality score [30 (equivalent to a base call accuracy
[99.9 %) and a read depth of at least 20, with KEGG
pathway ID(s) and with scores on biological impact of the
variant allele were selected. From the resulting list, a subset
of predicted damaging variants was further selected based
on the presence of both a SIFT score of 0.0 and a Poly-
Phen2 class ‘D’. The SIFT score is based on the premise
that the amino acid order of a protein is related to evolu-
tion. A SIFT score below 0.05 means that the amino acid is
highly conserved and substitution may result in damaging
of the function of the protein. In this regard, a SIFT score
of 0.0 indicates a high probability of damaging (Ng and
Henikoff 2003). PolyPhen2 takes structural features of the
protein into account to classify amino acid substitutions
like occurrence in a functional module and/or impact on
the 3D structure (Adzhubei et al. 2010). Substitutions are
quantitatively scored, but also qualitatively classified as
‘benign’ (B), ‘possibly damaging’ (P) and ‘probably
damaging’ (D). We took the last category into account.
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Thus, two SNP data files were composed: file A: all
annotated missense variants and file B: predicted damaging
missense variants. The amount of damaging missense
variants were evaluated by two parameters: (1) the ratio of
damaging missense variants to total missense variants,
which equals the number of missense variants per pathway
in file B/number of missense variants of the same pathway
in file A and (2) the burden, which equals the sum of
damaging missense variants per pathway per person.
Computational assessment of the function of PCDH
gene clusters
The genes of the PCDH alpha-, beta- and gamma-clusters
were used to infer coexpression data. Publically available
gene expression data (GEO http://www.ncbi.nlm.nih.gov/
geo/) for human and mouse were used to find genes that
coexpress with PCDH clusters. The approach is an exten-
sion of the one published by Baughman et al. (2009).
Shortly, using an in-house computational pipeline, all mi-
croarray experiment consisting of multiple expression
measurements was evaluated separately. Evaluation con-
sists of calculating the average Pearson’s coexpression of
each gene of the three PCDH clusters. If the coexpression
of the system (e.g., alpha-cluster) is congruent (on average,
genes are up- and downregulated together), a high weight is
assigned to the experiment. Analogously, if genes within
the system do not appear to coexpress with each other in
the experiment, the experiment itself receives a low weight.
After assigning weights to experiments, for each ex-
periment, the coexpression of each human gene is calcu-
lated with each of the clusters as average Pearson’s
correlation of expression. The results of coexpression with
the clusters are then integrated for all experiments (in a
weight-sensitive manner, as previously calculated) and for
both human and mouse. This gives the final list of genes
coexpressing with each cluster for which the top 100 was
Table 1 Subjects carrying rare
variants with a predicted
moderate-to-high biological
effect in PCDH genes
PCDH gene Subject code
3 8 13 14 16 19 21 22 23 26 28 30
Alpha-cluster
PCDHA6 X
PCDHA8 X
PCDHA12 X
Beta-cluster
PCDHB2 X
PCDHB3 X
PCDHB4 X
PCDHB8 X
PCDHB10 X
PCDHB14 X
PCDHB16 X
Gamma-cluster
PCDHGA8 X X
PCDHGB1 X X
PCDHGB7 X X
EXOME SEQUENCING
30 EXTREME OBESE
All SNPs
missense variants
phred quality score > 30
read depth at least 20
SIFT and PolyPhen2
values present
pathway indicaon
present
SIFT=0.0 and
PolyPhen2=D
FILE A:
all  missense variants
with SIFT and PolyPhen2
values and with pathway 
indicaon
n=53505
FILE B:
all  missense variants
with SIFT=0.0  and
PolyPhen2=D and with
pathway indicaon
n=1712
Fig. 1 Selection scheme for obtaining data files
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selected as genes most likely functionally related to PCDH
gene sets. As can be expected, those PCDH cluster-linked
gene sets contained several PCDH genes. For further ana-
lysis, those genes were removed resulting in a set of 83
genes for the alpha-cluster, 70 genes for the beta-cluster
and 65 genes for the gamma-cluster.
Next, these gene sets were analyzed by the program
DAVID (http://david.abcc.ncifcrf.gov/) to find functional
aspects that are specific for the different gene sets, which
would serve as an indicator for the function of the PCDH
cluster genes. Particular analyses involved the beta-linked
gene set against all genes in three sets as the background,
beta-linked gene set against all human genes, and alpha-
and beta-linked gene sets against all human genes.
The Genome of the Netherlands as control
We used the general Dutch population data as the control.
The Genome of the Netherlands database is represented by
the general Dutch population (www.nlgenome.nl) (Consor-
tium 2014). That project covered an area of 41,543 km2with
more than 17 million inhabitants and included the province
Limburg from where the present cohort was assembled. The
number of subjects is 498 in the extractable genome data-
base. A set of 353 non-pseudo-genes of olfactory receptors
(OR) was used to extract genome information. When no
information of the variant was available in theGenome of the
Netherlands, we used the data from large populations in the
dbSNP database (www.ncbi.nlm.nih.gov/snp).
Statistics
From the 30 extreme obese subjects, 12 are PCDH-variant
carriers, whereas 18 are non-carriers (Table 1). Chi-square
analysis was used to test whether the total number of
damaging missense variant hits in OR genes or in subsets
of those genes was different between the two groups. A hit
is defined as a hetero- or homozygous carrier of the altered
allele. A similar analysis was done to investigate the hits of
damaging missense variants in OR genes between carriers
of the previously identified PCDH alpha-, beta- or gamma-
cluster variants and the rest of the subjects. Mann–Whitney
test was used as an alternative method to compare PCDH-
variant carriers with non-carriers. A P = 0.05 was re-
garded as the threshold for significant deviation from the
null hypothesis.
Genetic association was assessed by Chi-square analysis
comparing the observed genotype frequencies in this ex-
treme obese cohort with the genotype frequencies reported
in the Genome of The Netherlands database or reported in
the dbSNP database.
The comparison on the burden of damaging missense
alleles was analyzed by Chi-square with Yates’
correction. In total, 2266 missense polymorphisms and
319 damaging missense polymorphisms were detected
either in the present cohort or in the controls. Those
were used to extract the number of total missense and
damaging missense alleles as the input for the data
shown in Table 3.
Results
Relation between the PCDH cluster
and the olfactory transduction pathway
In the olfactory transduction pathway, we scored in total
883 hits (hetero- or homozygous carrier of the altered al-
lele) of predicted damaging missense variants in 110
polymorphisms. All genes appeared to belong to the su-
perfamily of OR genes (Malnic et al. 2004). Almost half of
these hits, 432, were in genes on chromosome 11 and 146
in genes on chromosome 1, whereas 307 were in genes
distributed over 15 other chromosomes. For the total set of
hits of predicted damaging missense variants in the olfac-
tory transduction pathway, and in the three subgroups ac-
cording to the chromosome location, we tested by v2
analysis whether there might be a higher number of OR-
variant hits in PCDH-variant carriers than in non-carriers.
The results showed that significance was only reached for
the chromosome 1 subgroup (P = 0.023). Mann–Whitney
test gave similar results with significance only for the
chromosome 1 subgroup (P = 0.031, Fig. 2b).
To check the specificity of such co-damaging missense
variation between two pathways, we tested the tight junc-
tion and ABC receptor pathways in a similar way. These
two pathways were selected due to their high ratio of
damaging variants as mentioned later. For both pathways,
no significant relation between their variants and PCDH
variation was detected by v2 analysis (P = 0.78 and
P = 0.16, respectively) nor by Mann–Whitney test
(P = 0.79 and P = 0.06, respectively). Because of the
relatively low number of variants in these two pathways, no
subdivision according to chromosomes or genetic loci was
made.
Detailed analysis of olfactory transduction genes
on chromosome 1q
The 146 hits of predicted damaging missense variants in
OR genes on chromosome 1 were all located on the long
arm and divided over two loci at 1q23 (n = 26) and 1q44
(n = 120). In order to assess whether the observed relation
with PCDH variation could be ascribed to one of those loci
or to both, v2 analysis and the Mann–Whitney test were
used to compare the hits of variation between PCDH-
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variant carriers and non-carriers. v2 analysis resulted in a
trend for difference for 1q23 (P = 0.062) and 1q44
(P = 0.092), whereas the Mann–Whitney test resulted in
significance for 1q23 (P = 0.037) and a trend for 1q44
(P = 0.060). Apparently, both loci contribute to the effect
suggesting that genes from both locations cooperate with
PCDH genes in the genetic predisposition to extreme
obesity.
Table 2 gives a detailed overview of the involved OR
genes together with the polymorphisms and the IDs of the
subjects who are carriers of the risk alleles. It shows that
relatively common polymorphisms as well as rare variants
are involved. For all except one variant, the observed allele
frequencies were in line with that of the control general
populations. A comparison of the observed genotype dis-
tribution of the G/T variant in the OR14C36 gene
(rs28545014; D231Y) with that reported for the Genome of
the Netherlands indicated a genetic association between
this missense variant and extreme obesity (P\ 0.0001).
Using frequencies of the CS-Agilent population or of the
ESP-cohort populations from dbSNP did not alter this
finding (P = 0.001).
Detailed analysis of 1q OR genes and the PCDH
clusters
To determine whether the variation in the 1q OR genes
was linked with one of the PCDH clusters, the occur-
rence of hits of 1q OR predicted damaging missense
variants was compared per cluster among the subjects
with and without a PCDH variant. Similar analyses were
performed also for the 1q23 and 1q44 loci separately.
Subjects (ID # 14 and #19) with variants in genes of two
different PCDH clusters were counted in both of the
clusters. Significance for v2 analysis was only observed
for subjects with a PCDH beta-cluster variant regarding
all 1q OR variants (P\ 0.0001, Fig. 3b), variants on
1q23 (P = 0.014, Fig. 3c) and on 1q44 (P = 0.004,
Fig. 3d). Mann–Whitney test gave similar P values. It
indicates that the genetic cooperation between damaging
variation in the OR genes on chromosome 1q and var-
iation in the PCDH genes is confined to the PCDH beta-
cluster genes and does not occur with the alpha- and
gamma-clusters.
Extended functional assessment of PCDH gene
clusters
The functions of PCDH gene clusters were indirectly
assessed by the functions of their linked genes. Sets of
coexpressing genes were generated for each of the PCDH
clusters (Table S1) and functionally annotated to obtain an
indication of the specific function of the different PCDH
gene clusters. The outcome (Table S2) indicates that the
PCDH beta-cluster genes are linked to the control of tissue
development (‘DNA binding,’ ‘transcription regulation,’
‘cell cycle,’ ‘cell cycle phase’), whereas the PCDH-alpha
and gamma genes seem to be more engaged in neuron
organization and function (‘neuron projection,’ ‘cyto-
plasm,’ ‘synapse,’ ‘axon’).
Fig. 2 Relation between
olfactory transduction gene
variants and PCDH gene
variants. The distribution of
predicted damaging missense
variants in genes of the
olfactory transduction pathway
(hits per person) is shown in
subjects with (PCDH?) and
without (PCDH-) previously
identified rare PCDH variants.
a All variants annotated to
olfactory transduction genes;
b variants in olfactory
transduction genes on
chromosome 1; c variants in
olfactory transduction genes on
chromosome 11; d variants in
olfactory transduction genes all
other chromosomes than 1 and
11. The P value above each
graph was of Mann–Whitney
test
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The relevance of high number of damaging missense
variants in the olfactory transduction pathway
in extreme obesity
Olfactory transduction pathways showed high number of
damaging missense variants in our extreme obesity cohort.
We evaluated the ratio of predicted damaging missense
variant hits to total missense variant hits for various path-
ways. The olfactory transduction pathway together with the
tight junction pathway and ABC transporters pathway
formed the top three (Table S3). However, comparing our
cohort with the control on the number of damaging mis-
sense alleles in the olfactory transduction pathway per
person showed that extreme obese subjects even had a
lower burden than the general population (Table 3).
Discussion
The main olfactory system consists of the olfactory bulb,
where at the glomeruli neuronal cells are connected with
OR cells. When volatile chemicals are recognized by ORs,
a signal is transduced into perception and generates the
sensation of smell (Cleland 2014). Obviously, smell is an
important determinant of food selection and consumption
(Jaeger et al. 2013; Blundell and Finlayson 2004; Shepherd
2006; Reed and Knaapila 2010; Sorensen et al. 2003).
Close to 400 human OR genes distributed over 21 human
chromosomes constitute one of the largest gene families
(Hasin-Brumshtein et al. 2009; Malnic et al. 2004). The
high redundancy of ORs may make the system more ‘tol-
erant’ to damaging mutations. The embedded high genetic
variability of OR genes is well recognized (Mainland et al.
2014).
In the present study, we also confirmed that a relatively
large amount of missense variants with a predicted dam-
aging impact on protein function occurred in extreme
obesity. However, compared to the general population, it
even seems that extreme obese subjects carried less dam-
aging alleles. Nevertheless, different number of subjects
per sequenced cohort and different methods used in exome
capture and sequencing may eventually lead to the differ-
ence. In the general Dutch population, only 233 out of total
319 damaging missense polymorphisms were detected.
Fig. 3 Relation between OR
gene variants and PCDH beta-
cluster gene variants. The
distribution of predicted
damaging missense variants in
OR genes (hits per person) is
shown in subjects with (PCDH
b?) and without (PCDH b-)
previously identified rare
variants in the PCDH beta-
cluster genes. a All variants
annotated to olfactory
transduction genes; b variants in
OR genes on chromosome 1;
c variants in OR genes at 1q23;
d variants in OR genes at 1q44.
The P value above each graph
was of Mann–Whitney test
Table 3 Comparison of the burden for the olfactory transduction pathway
Extreme obesity Genome of the Netherlands P value
Total missense alleles per person 599 447 \0.0001
Ratio of damaging alleles to total missense alleles 5.8 % 8.9 % \0.0001
Burden of damaging missense alleles per person 34.5 39.8 \0.0001
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Because low-frequent damaging variants in the general
population are easy to be missed in our small cohort, this
might lead to an under-estimated burden in our extreme
obesity cohort in comparison with that of the control. A
rough calculation taking this under-estimation into account
would lead to no significant difference on the burden. For
the common 86 damaging missense polymorphisms, there
was also no difference on the burden between the extreme
obese and general Dutch population (29.1 vs. 29.5). These
results suggest at least that the high damaging genetic
variation of the olfactory transduction pathway, in either
ratio or absolute burden, is not specific to extreme obesity.
However, as indicated in the present and in few other
studies, there can still be genetic association between
particular ORs and obesity (Choquette et al. 2012; Jaeger
et al. 2013; Lunde et al. 2012; Jarick et al. 2011).
Here, we have shown that common and rare damaging
missense variants in OR genes on chromosome 1q are
carried more often by extreme obese subjects who also
carry variants with a moderate-to-low predicted biological
effect in the genes of the PCDH cluster on chromosome
5q31, in particular in the genes of the beta-cluster. Our
observations suggest a synergistic effect of genetic varia-
tion in genes of the PCDH beta-cluster and of the olfactory
transduction pathway on chromosome 1. The fact that the
rare variants in the PCDH genes were previously shown to
be implicated in extreme obesity [8] suggests that variation
in the OR genes and PCDH genes exerts an additive effect
on the risk of extreme obesity.
The link between the 1q OR and PCDH beta-cluster
genes suggests that they are involved in the same biological
process. The PCDH genes play a role in establishing neu-
ronal connectivity and synaptic specificity and maturation
in various regions of the central nervous system (Li et al.
2010). Although no clear specific functions have been an-
notated on the PCDH clusters, some experimental evidence
has shown non-exclusive roles of PCDH clusters in the
development of the olfactory system. During development
of the mouse, the maturation of the olfactory system re-
quires the coalescence of homotypic olfactory sensory
neurons into glomeruli of the olfactory bulb, which are
specified by ORs. Hasegawa et al. (2012) have proposed
that this is accomplished by two counteracting processes,
of which the coalescence is led by axon guidance mole-
cules like ephrin, semaphorin, plexin, BIG-2 and kirrel2/3,
and the repulsion of homotypic axons is mediated by the
alpha-protocadherins. However, the development of the
olfactory system is more complex and is also accompanied
by the expression of the PCDH beta- and gamma-cluster
genes (Hirano et al. 2012; Ledderose et al. 2013). The beta-
cluster has been proposed to play an important role in
neuron cell individuality [10]. It is in line with our bioin-
formatics analysis that suggests a specific role of those
genes in the control of gene expression and cell division,
and as such in tissue development. Our results also suggest
that the PCDH beta-cluster genes are involved in the de-
velopment of glomeruli of the olfactory system that in
humans are specified by the OR genes on chromosome 1q.
While studies on gene function in the mouse indicate that
the PCDH and OR genes mediate the development and fine-
tuning of the olfactory sensory system, our results suggest
that in humans OR genes on chromosome 1q and PCDH
beta-cluster genes may form two parts of one axis. The co-
impairment of these two parts can contribute to the risk of
extreme obesity at a relatively young age. Indeed, the human
olfactory system and its connection with the brain are com-
plex, and its importance for food selection and food intake is
obvious but has been largely overlooked (Shepherd 2006;
Palouzier-Paulignan et al. 2012). As a consequence, it is
unknown how the co-impairment of OR genes and PCDH
genes influences human olfaction. Theoretically, a poor
performance of this axismay inhibit thematuration of certain
olfactory glomeruli and induce less strong synaptic con-
nections with certain sensory neurons leading to impairment
of particular sense signals (Reed and Knaapila 2010), which
may reduce the food-rewarding circuits and stimulate the
body to eat more for compensation. On the other hand, the
inhibition of certain types of olfactory glomeruli may lead to
oversensitivity of others triggering stronger hedonic signals
to the brain (Blundell and Finlayson 2004). In this sense,
altered olfaction may also stimulate the food attraction.
Unfortunately, in humans, only a few ORs have been anno-
tated for their ligands. The gene OR10J5 located at 1q23 is
the human homolog of the murine gene for OR23, which
recognizes the odorant lyral with a perception of lemony
odor (Malnic et al. 2004). TheOR2M7 gene on 1q44 is likely
to be involved in the ability to smell methanethiol, which is
set free in the urine after eating asparagus (Eriksson et al.
2010). Obviously, knowledge about the ligands of the
specific ORs on chromosome 1q seems crucial for solving
the puzzle of these genes and their role in food intake.
The number of genetic studies looking into inter-indi-
vidual variation in smell perception is now rapidly in-
creasing (Keller et al. 2007; Reed and Knaapila 2010).
However, studies making the link with food intake are still
very limited. Lunde et al. (2012) showed that genetic
variation in the OR7D4 gene determines the level of
aversion to consume pork from male pigs containing an-
drostenone. Moreover, genetic variation in this gene and
other OR7 genes was reported to display genetic asso-
ciation with eating behavior and adiposity (Choquette et al.
2012). In another study, Jaeger et al. (2013) were able to
link preference for foods and products with added beta-
ionone to genetic variation in the OR5A1 gene. Interest-
ingly, a common copy number variant region was identified
on chromosome 11q11 associated with obesity and
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exclusively covering three OR genes, OR4p4, OR4S2 and
OR4C6 (Jarick et al. 2011). Our present results may add to
those studies by suggesting genetic association between
variation in the OR14C36 gene on 1q44 and extreme
obesity. Altogether, it is surprising how little genetic evi-
dence has been reported for the involvement of the OR
genes in weight regulation. This may be due to the fact that
complex gene–gene interactions play an important role
instead of single variations in the OR genes. In this respect,
a polygenic model will be more suitable to analyze OR
gene effects for obesity just like we have shown here.
It has been shown that morbidly obese subjects have an
olfactory dysfunction in comparison with moderately obese
individuals (Richardson et al. 2004). This has led to the
debate whether weight gain leads to impairment of the
olfactory function or whether it is the other way round. The
fact that weight loss after a gastric bypass does not improve
the olfactory sensation suggests that it is the olfactory
dysfunction that contributes to extreme obesity (Richard-
son et al. 2012). Our results may support the concept that
weight gain can be a consequence of an impaired olfactory
system, since a genetic influence from the olfactory system
together with PCDH genes underlying the risk of extreme
obesity is suggested here.
Recently, it was shown that ORs are expressed in other
tissues than the olfactory bulb. After feeding obesity-prone
and obesity-resistant rats a high-fat diet for 14 days, mi-
croarray analysis showed up-regulation of four OR genes in
duodenal enterocytes of the obesity-prone animals (Pri-
meaux et al. 2013). It suggests that these receptors play a
role in sensing nutrients or their metabolites as they pass
through the lumen of the gut, and assist in regulating their
uptake. In lung epithelium of the mouse, it was found that
beta-carotene simultaneously up-regulates 26 OR genes and
9 genes of the PCDH beta-cluster. It was proposed that
those genes might be active in the highly innervated pul-
monary neuroendocrine cell clusters (van Helden et al.
2010), which may have various functions like lung tissue
repair, sensing volatile chemicals and monitoring oxygen
levels in the inhaled air (Song et al. 2012; Gu et al. 2014). A
link with chronic obstructive pulmonary disease (COPD)
has been suggested (Gu et al. 2014), but not with obesity.
Obviously, our knowledge about the functional cooperation
of PCDH and OR genes in the human body is still very
limited, and this cooperation may not only occur in the
extreme obesity context. Until we obtain more knowledge,
our present findings cannot be definitely ascribed to aspects
of smell sensation.
The present findings are based on the analysis of whole
exome sequencing data and partly comply with the sug-
gested guidelines for quality (MacArthur et al. 2014). For
instance, we predicted missense variants to be damaging by
using a combination of two functional annotation
programs, SIFT and PolyPhen2. Also, we did not assume
that the implicated variants or combinations thereof were
fully penetrant. Nevertheless, our work is based on a lim-
ited number of subjects and our findings need to be con-
firmed in a similar, independent study.
Conclusions
In summary, we found that predicted damaging missense
variants in OR genes on chromosome 1q and rare damag-
ing variants in PCDH beta-cluster genes on 5q31 co-lo-
calize in subjects with extreme obesity, suggesting a
synergistic effect in the predisposition to this condition.
Further, mechanistic insight may come from the identifi-
cation of the ligands of the 1q ORs linked to the PCDH
beta-cluster. Eventually, this may provide the possibility to
manipulate food flavor in a way to reduce the risk of
overeating and extreme obesity in some genetically pre-
disposed subjects.
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